154 related articles for article (PubMed ID: 6381191)
1. Hyperinsulinaemia in non-cirrhotic haemochromatosis: impaired hepatic insulin degradation?
Niederau C; Berger M; Stremmel W; Starke A; Strohmeyer G; Ebert R; Siegel E; Creutzfeldt W
Diabetologia; 1984 Jun; 26(6):441-4. PubMed ID: 6381191
[TBL] [Abstract][Full Text] [Related]
2. The entero-insular axis in polycystic ovarian syndrome.
Gama R; Norris F; Wright J; Morgan L; Hampton S; Watkins S; Marks V
Ann Clin Biochem; 1996 May; 33 ( Pt 3)():190-5. PubMed ID: 8791980
[TBL] [Abstract][Full Text] [Related]
3. Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance.
Rask E; Olsson T; Söderberg S; Holst Jj Jj; Tura A; Pacini G; Ahrén B
Metabolism; 2004 May; 53(5):624-31. PubMed ID: 15131768
[TBL] [Abstract][Full Text] [Related]
4. Elevated plasma glucose-dependent insulinotropic polypeptide associates with hyperinsulinemia in impaired glucose tolerance.
Theodorakis MJ; Carlson O; Muller DC; Egan JM
Diabetes Care; 2004 Jul; 27(7):1692-8. PubMed ID: 15220248
[TBL] [Abstract][Full Text] [Related]
5. Beta and alpha cell function in metabolically healthy but obese subjects: relationship with entero-insular axis.
Calanna S; Piro S; Di Pino A; Maria Zagami R; Urbano F; Purrello F; Maria Rabuazzo A
Obesity (Silver Spring); 2013 Feb; 21(2):320-5. PubMed ID: 23404781
[TBL] [Abstract][Full Text] [Related]
6. Patients With Long-QT Syndrome Caused by Impaired
Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
[TBL] [Abstract][Full Text] [Related]
7. Glucose-induced incretin hormone release and insulin sensitivity are impaired in patients with idiopathic gastroparesis: results from a pilot descriptive study.
Prévost G; Ducrotté P; Cailleux A; Khalfi K; Basuyau JP; Lefebvre H; Kuhn JM
Neurogastroenterol Motil; 2013 Aug; 25(8):694-9. PubMed ID: 23663508
[TBL] [Abstract][Full Text] [Related]
8. Release of glucagon-like peptide 1 (GLP-1 [7-36 amide]), gastric inhibitory polypeptide (GIP) and insulin in response to oral glucose after upper and lower intestinal resections.
Nauck MA; Siemsglüss J; Orskov C; Holst JJ
Z Gastroenterol; 1996 Mar; 34(3):159-66. PubMed ID: 8650968
[TBL] [Abstract][Full Text] [Related]
9. Hyperinsulinaemia of hypertriglyceridaemia: a reappraisal.
Gama R; Shah S; Wright J; Marks V
Diabet Med; 1995 Apr; 12(4):321-4. PubMed ID: 7600747
[TBL] [Abstract][Full Text] [Related]
10. Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes.
Nauck MA; El-Ouaghlidi A; Gabrys B; Hücking K; Holst JJ; Deacon CF; Gallwitz B; Schmidt WE; Meier JJ
Regul Pept; 2004 Nov; 122(3):209-17. PubMed ID: 15491793
[TBL] [Abstract][Full Text] [Related]
11. The reduction in hepatic insulin clearance after oral glucose is not mediated by gastric inhibitory polypeptide (GIP).
Meier JJ; Gallwitz B; Siepmann N; Holst JJ; Deacon CF; Schmidt WE; Nauck MA
Regul Pept; 2003 May; 113(1-3):95-100. PubMed ID: 12686467
[TBL] [Abstract][Full Text] [Related]
12. Insulin, C-peptide and glucagon levels during OGTT in hepatic cirrhosis and in patients with prehepatic block.
Gerö L; Korányi L; Szalay F; Büki B; Tamás G
Acta Diabetol Lat; 1982; 19(1):55-64. PubMed ID: 7041501
[TBL] [Abstract][Full Text] [Related]
13. Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance.
Lanng S; Thorsteinsson B; Røder ME; Orskov C; Holst JJ; Nerup J; Koch C
Acta Endocrinol (Copenh); 1993 Mar; 128(3):207-14. PubMed ID: 8480468
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms Regulating Insulin Response to Intragastric Glucose in Lean and Non-Diabetic Obese Subjects: A Randomized, Double-Blind, Parallel-Group Trial.
Meyer-Gerspach AC; Cajacob L; Riva D; Herzog R; Drewe J; Beglinger C; Wölnerhanssen BK
PLoS One; 2016; 11(3):e0150803. PubMed ID: 26942445
[TBL] [Abstract][Full Text] [Related]
15. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
[TBL] [Abstract][Full Text] [Related]
16. Hyperinsulinaemia and insulin resistance of cirrhosis: the importance of insulin hypersecretion.
Proietto J; Dudley FJ; Aitken P; Alford FP
Clin Endocrinol (Oxf); 1984 Dec; 21(6):657-65. PubMed ID: 6391746
[TBL] [Abstract][Full Text] [Related]
17. Increased postprandial GIP and glucagon responses, but unaltered GLP-1 response after intervention with steroid hormone, relative physical inactivity, and high-calorie diet in healthy subjects.
Hansen KB; Vilsbøll T; Bagger JI; Holst JJ; Knop FK
J Clin Endocrinol Metab; 2011 Feb; 96(2):447-53. PubMed ID: 21047927
[TBL] [Abstract][Full Text] [Related]
18. Effects of physical training on insulin, connecting peptide (C-peptide), gastric inhibitory polypeptide (GIP) and pancreatic polypeptide (PP) levels in obese subjects.
Krotkiewski M; Björntorp P; Holm G; Marks V; Morgan L; Smith U; Feurle GE
Int J Obes; 1984; 8(3):193-9. PubMed ID: 6378815
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of hyperinsulinaemia in Child's disease grade B liver cirrhosis investigated in free living conditions.
Greco AV; Mingrone G; Mari A; Capristo E; Manco M; Gasbarrini G
Gut; 2002 Dec; 51(6):870-5. PubMed ID: 12427792
[TBL] [Abstract][Full Text] [Related]
20. Plasma C-peptide and insulin responses to intravenous glucagon stimulation in idiopathic haemochromatosis.
Rumbak MJ; Joffe BI; Seftel HC; Kalk WJ; Bezwoda WR; Bothwell TH
S Afr Med J; 1987 Mar; 71(6):351-3. PubMed ID: 3551126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
